Curanex Pharmaceuticals Inc (NASDAQ:CURX – Get Free Report) rose 1.6% during trading on Tuesday . The company traded as high as $0.63 and last traded at $0.5951. Approximately 82,323 shares traded hands during trading, a decline of 87% from the average daily volume of 624,413 shares. The stock had previously closed at $0.5858.
Analyst Upgrades and Downgrades
Separately, Wall Street Zen raised shares of Curanex Pharmaceuticals to a “hold” rating in a report on Saturday, August 30th.
Read Our Latest Stock Report on CURX
Curanex Pharmaceuticals Stock Up 1.6%
Curanex Pharmaceuticals Company Profile
Curanex is a developmental stage pharmaceutical company dedicated to discovering, developing and commercializing innovative botanical drugs to treat patients suffering from inflammatory diseases. Our mission is to address significant unmet medical needs and improve patients’ lives by harnessing the power of natural substances.
See Also
- Five stocks we like better than Curanex Pharmaceuticals
- Asset Allocation Strategies in Volatile Markets
- CoreWeave’s Guidance Cut: A Buying Opportunity in Disguise?
- Do ETFs Pay Dividends? What You Need to Know
- Strategy Shares Plunge as Bitcoin Retreats—More Pain Ahead?
- TSX Venture Exchange (Formerly Canadian Venture Exchange)
- BigBear.ai Stock Is Range-Bound—Wall Street Isn’t Buying the Hype
Receive News & Ratings for Curanex Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Curanex Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
